BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
2/17/2022 9:46:13 AM | Browse: 564 | Download: 1171
 |
Received |
|
2021-08-13 21:06 |
|
Peer-Review Started |
|
2021-08-13 21:12 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2021-09-04 01:02 |
|
Revised |
|
2021-09-17 18:05 |
|
Second Decision |
|
2022-01-19 03:57 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2022-01-20 04:08 |
|
Articles in Press |
|
2022-01-20 04:08 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
2022-01-14 04:14 |
|
Typeset the Manuscript |
|
2022-02-07 02:39 |
|
Publish the Manuscript Online |
|
2022-02-17 09:46 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Letter to the Editor |
| Article Title |
Gastrointestinal microbiome and Helicobacter pylori: Eradicate, leave it as it is, or take a personalized benefit–risk approach?
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Stanislav Sitkin, Leonid Lazebnik, Elena Avalueva, Svetlana Kononova and Timur Vakhitov |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Russian Science Foundation |
Project No. 20-65-47026 |
|
| Corresponding Author |
Stanislav Sitkin, MD, PhD, Associate Professor, Senior Researcher, Department of Internal Diseases, Gastroenterology and Dietetics, North-Western State Medical University named after I.I. Mechnikov, Kirochnaya Street, 41, St. Petersburg 191015, Russia. drsitkin@gmail.com |
| Key Words |
Helicobacter pylori; Eradication; Gastrointestinal microbiota; Dysbiosis; Fucosylated glycan; Inflammatory bowel disease |
| Core Tip |
Helicobacter pylori (H. pylori) is generally regarded as a human pathogen, but it can act as a commensal symbiont. H. pylori colonization may have beneficial effects on the host by regulating gastrointestinal microbiota and protecting against some allergic and autoimmune disorders and inflammatory bowel disease. H. pylori eradication can cause various adverse effects and alter the gastrointestinal microbiota, leading to dysbiosis. Therefore, eradication cannot be an unconditional recommendation in every case of H. pylori infection, and the therapeutic decision should be based on a personalized assessment of the benefit vs risk. |
| Publish Date |
2022-02-17 09:46 |
| Citation |
Sitkin S, Lazebnik L, Avalueva E, Kononova S, Vakhitov T. Gastrointestinal microbiome and Helicobacter pylori: Eradicate, leave it as it is, or take a personalized benefit–risk approach? World J Gastroenterol 2022; 28(7): 766-774 |
| URL |
https://www.wjgnet.com/1007-9327/full/v28/i7/766.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v28.i7.766 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
